TP53 and cancer: Moreover, reduced TIMP-3 in cancer cells was associated with reduced recurrence-free survival in the 100 lymph-node-positive cases (p = 0.007; Figure 4a) and in the subset of 118 p53-negative cancers (p = 0.037; Figure 4b).